Hayfin Capital Management

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

MolecuLight specializes in innovative imaging solutions for wound care, particularly in the detection of harmful bacteria and the measurement of wounds. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess tissue viability at the point of care. These devices facilitate the documentation and monitoring of wound healing progress, enabling healthcare professionals to select the appropriate therapy for their patients in a timely manner. By providing accurate analysis and procedural guidance, MolecuLight's technology aims to enhance patient outcomes in wound management.

Xeris Biopharma is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for patient populations in endocrinology, neurology, and gastroenterology. The company utilizes its proprietary formulation technologies, XeriSol and XeriJect, to create ready-to-use, liquid-stable injectables that can deliver highly concentrated, non-aqueous formulations of peptides, proteins, antibodies, and small molecules. These technologies facilitate subcutaneous and intramuscular delivery, offering distinct advantages over traditional formulations, such as eliminating the need for reconstitution and enabling long-term room temperature stability. Xeris currently markets three products: Gvoke, a ready-to-use liquid glucagon for severe hypoglycemia; Keveyis, the first FDA-approved treatment for primary periodic paralysis; and Recorlev, approved for endogenous hypercortisolemia in Cushing's Syndrome. Additionally, the company has an extensive pipeline of development programs aimed at expanding its product offerings through its advanced formulation science.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to support buyers and suppliers in accelerating their business growth through innovative financial services. KEO World operates in the United States, Mexico, and throughout Latin America via its Global Trade program. Utilizing artificial intelligence and machine learning, KEO's platform analyzes banking transactional data to provide potential customers with rapid access to maximum funding. This approach enables businesses and consumers to secure instant financial support, streamlining the financing process and enhancing overall operational efficiency.

ADMA Biologics is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics primarily for the treatment of immune deficiencies and infectious diseases. The company's product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin products used for treating primary humoral immunodeficiency, as well as Nabi-HB, which is indicated for exposure to Hepatitis B. ADMA serves niche patient populations, particularly those who are immunocompromised or immune-suppressed due to medical conditions. To support its product development, ADMA operates FDA-licensed plasma collection facilities known as ADMA BioCenters, which supply plasma for its biologics. The company distributes its products through a network of independent distributors, specialty pharmacies, and alternate site providers. Founded in 2004 and headquartered in Ramsey, New Jersey, ADMA Biologics continues to advance its pipeline of plasma-derived therapeutics aimed at preventing and treating infections.

KEO World is a FinTech company based in Miami, Florida, that specializes in all-digital inventory financing and B2B payment solutions. The company aims to support buyers and suppliers in accelerating their business growth through innovative financial services. KEO World operates in the United States, Mexico, and throughout Latin America via its Global Trade program. Utilizing artificial intelligence and machine learning, KEO's platform analyzes banking transactional data to provide potential customers with rapid access to maximum funding. This approach enables businesses and consumers to secure instant financial support, streamlining the financing process and enhancing overall operational efficiency.

Avadim Health is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products for both institutional care and consumer markets. Utilizing its Bionome Engineered Platform, the company focuses on enhancing topical immune health, neuromuscular health, and skin barrier health. Avadim Health offers a range of products designed to alleviate pain, infections, muscle cramps, spasms, symptoms of restless leg syndrome, and joint discomfort. These products are distributed to various retail outlets, including grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, the company provides consulting services and sells its products online. Founded in 2007 and initially known as Avadim Technologies, the company rebranded to Avadim Health in September 2018.

Frans Bonhomme is a distributor based in Joué-lès-Tours, France, specializing in a diverse range of products related to water supply and drainage systems. The company offers an extensive selection of PVC and polyethylene pipes, fittings, and accessories, as well as cast iron networks, corrugated pipes, manholes, and wastewater equipment. Their product lineup supports various applications, including plumbing, heating, sanitation, landscaping, and irrigation. By focusing on quality, Frans Bonhomme serves multiple markets, including drainage, drinking water, rainwater, and wastewater management, ensuring that customers have access to reliable and effective solutions.

Amicus Therapeutics is a biotechnology company dedicated to discovering, developing, and commercializing therapies for rare and orphan diseases. The company is known for its product Galafold, an orally administered small molecule pharmacological chaperone specifically designed for treating Fabry disease. Amicus is also advancing its clinical pipeline, including a Phase 3 study of AT-GAA for Pompe disease. The company focuses on creating novel therapies, particularly pharmacological chaperones, which are intended to stabilize and enhance the activity of misfolded enzymes in patients. This approach may improve treatment outcomes, especially when used in conjunction with enzyme replacement therapy. Amicus Therapeutics was founded in 2002 and is headquartered in Cranbury, New Jersey, collaborating with institutions like Nationwide Children's Hospital and the University of Pennsylvania to further its research and development efforts.

GC Aesthetics is a company focused on female aesthetics, specializing in the development, manufacturing, and commercialization of silicone breast implants. The company offers a variety of surgical implants and tissue expanders that provide surgeons with options for breast augmentation, aesthetic enhancement, and reconstructive surgery. Additionally, GC Aesthetics develops silicone products for scar management, including a product line designed to improve the appearance of scars. The company also supports patients and surgeons through educational resources and a patient generator program known as Business Boost. With its headquarters in Dublin, Ireland, and manufacturing facilities located in Scotland, England, and France, GC Aesthetics serves both local and international markets, emphasizing innovation and quality to enhance the body transformation journey for women. Established in 2015, the company leverages over 30 years of industry experience to empower individuals and promote confidence in their aesthetic choices.

Avadim Health is a healthcare and wellness company based in Asheville, North Carolina, specializing in the development, manufacturing, and marketing of topical products for both institutional care and consumer markets. Utilizing its Bionome Engineered Platform, the company focuses on enhancing topical immune health, neuromuscular health, and skin barrier health. Avadim Health offers a range of products designed to alleviate pain, infections, muscle cramps, spasms, symptoms of restless leg syndrome, and joint discomfort. These products are distributed to various retail outlets, including grocery stores and pharmacies, as well as acute-care hospitals, nursing homes, and other long-term care facilities. Additionally, the company provides consulting services and sells its products online. Founded in 2007 and initially known as Avadim Technologies, the company rebranded to Avadim Health in September 2018.

Kingsland Capital is an employee-owned investment manager that specializes in managing investment portfolios focused on fixed income markets. The firm provides services to funds and collateralized loan obligations, primarily investing in corporate debt securities, high yield bonds, distressed assets, and leveraged loans. Kingsland Capital employs a combination of fundamental and technical analysis to develop its investment strategies and create diversified portfolios that effectively address the complexities of high yield, leveraged, and distressed asset classes.

NKD Group is a retailer specializing in textiles and home accessories, providing a diverse range of products for households, teenagers, and the sports sector. The company offers fashionable apparel for men, women, and children, including dresses, blouses, trousers, and jackets, catering to various tastes and fashion trends. In addition to clothing, NKD provides functional sportswear and home textiles, along with seasonal decoration items. The company's offerings are available through both online and offline stores, ensuring customers have access to a wide selection of affordable fashion and essential home goods. Regular updates to their inventory include seasonal novelties and trendy items, making NKD a comprehensive destination for contemporary fashion and home accessories.